EKF Diagnostics Holdings

EKF · AIM · Health Care · mcap £106m · 26.0p

Beta Briefing, track record and bull & bear case are not ready for EKF Diagnostics Holdings yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 15 Sep 26 ↗

Revenue: £51.4m
Operating profit: £6.7m
Net income: £2.5m
Free cash flow: £4.2m
Net cash: £16.0m
Market cap: £111m
EV / EBIT: 14.4×
FCF yield: +3.8%
Price / book: 1.6×

Latest half-year · H1 26 vs H1 25 results 15 Sep 26 ↗

Revenue: £25.0m
Operating profit: £3.3m
Net income: £2.3m
Cash from operations: £3.3m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 15 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	51.4	51.6	50.2
Gross profit	27.1	26.5	24.1
Adjusted EBITDA	12.5	12.4	11.3
EBITDA	–	12.4	–
Exceptional / adjusting items	(0.3)	0.0	–
Operating profit	6.7	7.0	6.3
Depreciation (owned assets)	3.1	3.1	–
Amortisation	2.4	2.3	–
Share-based payments	(0.0)	(0.0)	–
Finance costs	(0.2)	(0.2)	(0.2)
Profit before tax	6.9	7.1	6.3
Tax	(4.0)	(4.6)	0.3
Net income (owners)	2.5	2.1	6.2
EPS basic	0.6p	0.5p	1.4p
EPS diluted	0.6p	0.5p	1.4p

	H1 26	vs H1 25	H2 25	H1 25
Revenue	25.0	−1%	26.3	25.2
Gross profit	13.3	+5%	13.8	12.7
Adjusted EBITDA	5.9	+2%	6.6	5.8
EBITDA	5.6	–	–	–
Exceptional / adjusting items	(0.3)	n/m	0.0	0.0
Operating profit	3.3	−7%	3.4	3.6
Depreciation (owned assets)	1.6	+1%	1.4	1.6
Amortisation	0.6	+14%	1.8	0.6
Share-based payments	(0.0)	n/m	(0.0)	0.0
Finance costs	(0.1)	n/m	(0.1)	(0.0)
Profit before tax	3.4	−6%	3.5	3.6
Tax	(0.9)	−38%	(3.0)	(1.5)
Net income (owners)	2.3	+19%	0.2	1.9
EPS basic	0.5p	–	0.0p	0.4p
EPS diluted	0.5p	–	0.0p	0.4p

	LTM Jun 26	FY 25	FY 24
Cash from operations	8.1	9.7	13.7
Interest paid	(0.0)	(0.0)	(0.1)
Tax paid	(3.3)	(2.2)	1.4
Capex (PP&E)	(1.9)	(1.5)	(2.2)
Capex (intangibles)	(1.4)	(0.8)	(0.5)
Lease principal paid	(0.6)	(0.5)	(0.7)
Share buybacks	(4.9)	(5.0)	–

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	3.3	−33%	4.8	4.9
Interest paid	0.0	n/m	(0.0)	(0.0)
Tax paid	(1.7)	+187%	(1.6)	(0.6)
Capex (PP&E)	(0.9)	+78%	(1.0)	(0.5)
Capex (intangibles)	(1.0)	+131%	(0.4)	(0.5)
Lease principal paid	(0.3)	+22%	(0.2)	(0.3)
Share buybacks	(0.9)	−9%	(4.0)	(1.0)

	Latest Jun 26	FY 25	FY 24
Other intangibles	28.2	27.9	28.9
Property, plant & equipment	20.6	21.0	22.8
Other investments	0.0	0.1	0.2
Inventories	9.1	8.3	7.4
Trade receivables	7.0	6.7	6.8
Cash	16.0	15.8	14.3
Current assets	32.2	30.9	28.6
Total assets	82.3	81.1	81.7
Trade payables	5.9	5.3	5.4
Lease liabilities, current	0.3	0.4	0.4
Current liabilities	6.8	7.4	6.4
Lease liabilities, non-current	1.1	1.0	0.9
Total liabilities	10.8	10.9	8.5
Non-controlling interests	1.2	1.2	0.9
Total equity	71.6	70.3	73.2
Treasury shares	–	0.0m	0.0m

	H1 26	H2 25	H1 25	H2 24
Other intangibles	28.2	27.9	28.8	28.9
Property, plant & equipment	20.6	21.0	20.8	22.8
Other investments	0.0	0.1	0.2	0.2
Inventories	9.1	8.3	7.8	7.4
Trade receivables	7.0	6.7	7.1	6.8
Cash	16.0	15.8	16.6	14.3
Current assets	32.2	30.9	31.5	28.6
Total assets	82.3	81.1	82.4	81.7
Trade payables	5.9	5.3	5.8	5.4
Lease liabilities, current	0.3	0.4	0.2	0.4
Current liabilities	6.8	7.4	6.8	6.4
Lease liabilities, non-current	1.1	1.0	0.9	0.9
Total liabilities	10.8	10.9	9.6	8.5
Non-controlling interests	1.2	1.2	1.1	0.9
Total equity	71.6	70.3	72.9	73.2
Treasury shares	–	0.0m	–	0.0m

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.